NY A10478

Insurance carriers and health plans must cover at least one abuse-deterrent opioid analgesic drug product per opioid analgesic active ingredient on their formulary or drug list.

Cost-sharing for brand name abuse-deterrent opioid drugs cannot exceed the lowest cost-sharing level applied to brand name non-abuse deterrent opioid drugs under the same health plan or policy.

Cost-sharing for generic abuse-deterrent opioid drugs cannot exceed the lowest cost-sharing level applied to generic non-abuse deterrent opioid drugs under the same health plan or policy.

Prior-authorization requirements and utilization review measures for opioid analgesics cannot require patients to use non-abuse-deterrent opioid products first in order to access abuse-deterrent opioid products.

The act takes effect 120 days after becoming law and applies to all policies and contracts issued, renewed, modified, altered or amended on or after that date.